Maravai LifeSciences Holdings, Inc. (MRVI) Operating income 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) annual operating income history from SEC filings — each fiscal year as reported.
-$215.3MFY2025 · since FY2019: $24.0M → -$215.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$215.3M | +8.6% |
| FY2024 | -$235.6M | -644.5% |
| FY2023 | -$31.6M | -105.5% |
| FY2022 | $574.2M | +3.5% |
| FY2021 | $554.6M | +362.6% |
| FY2020 | $119.9M | +399.8% |
| FY2019 | $24.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRVI financial trends
MRVI RevenueMRVI Net incomeMRVI Net marginMRVI Gross profitMRVI Gross marginMRVI Operating marginMRVI Operating cash flowMRVI Free cash flowMRVI Capital expendituresMRVI Return on equityMRVI Stock buybacksMRVI Dividends paidMRVI Total assetsMRVI Total liabilitiesMRVI Shareholders’ equityMRVI overview →